[HTML][HTML] Determinants of antibody responses to SARS-CoV-2 vaccines: population-based longitudinal study (COVIDENCE UK)

DA Jolliffe, SE Faustini, H Holt, N Perdek, S Maltby… - Vaccines, 2022 - mdpi.com
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …

Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK).

DA Jolliffe, SE Faustini, H Holt, N Perdek… - Vaccines, 2022 - search.ebscohost.com
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …

Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)

DA Jolliffe, SE Faustini, H Holt, N Perdek… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …

Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK).

DA Jolliffe, SE Faustini, H Holt, N Perdek, S Maltby… - Vaccines, 2022 - europepmc.org
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …

Determinants of antibody responses to SARS-CoV-2 vaccines: population-based longitudinal study (COVIDENCE UK).

DA Jolliffe, SE Faustini, H Holt, N Perdek, S Maltby… - 2022 - cabidigitallibrary.org
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …

[引用][C] Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)

DA Jolliffe, SE Faustini, H Holt, N Perdek, S Maltby… - VACCINES, 2022 - qmro.qmul.ac.uk
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based
Longitudinal Study (COVIDENCE UK) Toggle navigation Login Toggle navigation …

[HTML][HTML] Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)

DA Jolliffe, SE Faustini, H Holt, N Perdek, S Maltby… - Vaccines, 2022 - ncbi.nlm.nih.gov
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …

Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)

DA Jolliffe, SE Faustini, H Holt, N Perdek, S Maltby… - Vaccines, 2022 - search.proquest.com
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …

Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)

DA Jolliffe, SE Faustini, H Holt, N Perdek, S Maltby… - Vaccines, 2022 - research.ed.ac.uk
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …

[引用][C] Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)

DA Jolliffe, SE Faustini, H Holt, N Perdek, S Maltby… - Age, 2022 - europepmc.org
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly
understood. A range of sociodemographic, behavioural, clinical, pharmacologic and …